Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.
Leander CorrieAnkit AwasthiJaskiran KaurSukriti VishwasMonica GulatiIndu Pal KaurGaurav GuptaNagavendra KommineniKamal DuaDinesh Kumar ChellapanPublished in: Pharmaceuticals (Basel, Switzerland) (2023)
Polycystic Ovarian Syndrome (PCOS) comprises a set of symptoms that pose significant risk factors for various diseases, including type 2 diabetes, cardiovascular disease, and cancer. Effective and safe methods to treat all the pathological symptoms of PCOS are not available. The gut microbiota has been shown to play an essential role in PCOS incidence and progression. Many dietary plants, prebiotics, and probiotics have been reported to ameliorate PCOS. Gut microbiota shows its effects in PCOS via a number of mechanistic pathways including maintenance of homeostasis, regulation of lipid and blood glucose levels. The effect of gut microbiota on PCOS has been widely reported in animal models but there are only a few reports of human studies. Increasing the diversity of gut microbiota, and up-regulating PCOS ameliorating gut microbiota are some of the ways through which prebiotics, probiotics, and polyphenols work. We present a comprehensive review on polyphenols from natural origin, probiotics, and fecal microbiota therapy that may be used to treat PCOS by modifying the gut microbiota.
Keyphrases
- polycystic ovary syndrome
- type diabetes
- cardiovascular disease
- blood glucose
- glycemic control
- endothelial cells
- metabolic syndrome
- risk factors
- squamous cell carcinoma
- bone marrow
- fatty acid
- blood pressure
- stem cells
- young adults
- coronary artery disease
- depressive symptoms
- physical activity
- adverse drug
- human health
- cardiovascular risk factors
- cell therapy